MedQube

Kanalga Telegram’da o‘tish

#رابط القناة 👇👇 https://t.me/DrMustafa8 #قناة تخص المراحل السريرية ( الرابعة الخامسة السادسة ) لكليات الطب والإقامة الدورية (History, Examination , common topic , overlap … Etc) رابط قناة اليوتيوب👇👇 https://youtube.com/@shefa.iq_9?si=JyJiJs4jAWXYhjIz

Ko'proq ko'rsatish

Iroq10 582 Tibbiyot2 365...

📈 Telegram kanali MedQube analitikasi

MedQube (@drmustafa8) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 11 437 obunachidan iborat bo'lib, Tibbiyot toifasida 2 365-o'rinni va Iroq mintaqasida 10 582-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 11 437 obunachiga ega bo‘ldi.

13 Iyul, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 2 ga, so‘nggi 24 soatda esa 3 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

Tasdiqlash holati: Tasdiqlanmagan
Jalb etish (ER): Auditoriya o‘rtacha 14.65% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 6.22% ini tashkil etuvchi reaksiyalarni to‘playdi.
Post qamrovi: Har bir post o‘rtacha 1 675 marta ko‘riladi; birinchi sutkada odatda 711 ta ko‘rish yig‘iladi.
Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 6 ta reaksiya keladi.
Tematik yo‘nalishlar: Kontent الي, بَثّ, تَشرِيح, سَلَام, طَرِيقَة kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“#رابط القناة 👇👇 https://t.me/DrMustafa8 #قناة تخص المراحل السريرية ( الرابعة الخامسة السادسة ) لكليات الطب والإقامة الدورية (History, Examination , common topic , overlap … Etc) رابط قناة اليوتيوب👇👇 https://youtube.com/@shefa.iq_9?si=JyJiJs4j...”

Yuqori yangilanish chastotasi (oxirgi ma’lumot 14 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

11 437

Obunachilar

+324 soatlar

+467 kunlar

+230 kunlar

1 675

Post ko'rishlar

~ 71124 soatlar

~ 86448 soatlar

14.65%

Muloqot nisbati

Ma'lumot yo'q

Kuniga postlar

Ads index

beta

Postlar arxiv

11 438

Ovozli xabar01:37

11 438

هدية القناة الكم اخر واحدث نسخة من كتاب ديفدسون Davidson's Principles and Practice of Medicine 25th Edition

11 438

In shock states, regardless of the type of shock, the main problem is inadequate organ perfusion. The most important pressure value related to organ perfusion is the MAP, which stands for Mean Arterial Pressure, not “main arterial pressure.” MAP can be estimated using this formula: MAP = DBP + 1/3(SBP − DBP) For example, a blood pressure of 90/60 mmHg gives a MAP of about 70 mmHg, which is usually acceptable as an initial perfusion target. In shock, the usual initial target is MAP ≥ 65 mmHg. However, we should not decide to start vasopressors based only on a blood pressure below 90/60 mmHg. The decision depends on whether the patient has hypotension with signs of organ hypoperfusion, such as altered mental status, low urine output, cold extremities, delayed capillary refill, metabolic acidosis, or elevated lactate. In general, vasopressors are started when hypotension or hypoperfusion persists despite appropriate initial resuscitation, especially after adequate fluid resuscitation if the patient is fluid responsive. In severe hypotension, vasopressors may be started early while resuscitation is ongoing. In septic shock, the first-line vasopressor is usually norepinephrine, and the initial target is MAP ≥ 65 mmHg. Weaning vasopressors could begin simply used because the blood pressure rises above 90/60 mmHg. ومعها ايضا We start reducing vasopressors when the patient has a stable MAP, usually ≥65 mmHg, along with improvement in organ perfusion, such as improving mental status, adequate urine output, decreasing lactate, better skin perfusion, and control of the underlying cause of shock.

11 438

البوردجية سوال شوكت ابلش Vasopressor وشوكت وشلون اوقف

11 438

Ovozli xabar00:18

11 438

Ovozli xabar00:15

11 438

الجواب ببساطة يستمر على نفس الجرعةً

11 438

Ovozli xabar00:18

11 438

سؤال عملي للبوردجيةً A patient with dyslipidemia reached the guideline-recommended LDL-C target after treatment with a statin. Should the statin dose be reduced, discontinued, or continued?

11 438

Ovozli xabar00:46

11 438

Ovozli xabar00:54

11 438

دكتور هسة بعيداً عن التشخيص النهائي الي طلع مثلا واجهنة هيج مريض ،،، 1 asymptomatic 2 خلي نختصر ال finding كلهة ب Suspicious ecg هيج مريض مو لازم يندز troponin يلة وراها echo ؟

11 438

سؤال حلو

11 438

Ovozli xabar00:55

11 438

همزين ما داخل الطوارئ لان جان وصل حتى CCU 🤣🤣

11 438

ارجعكم لنظام الحزورات الي تحبوه بدون هستري شنو نشوف بال ECG

11 438

PFO

11 438

ASD شوية

11 438

اَلسَّلامُ عَلَى الْحُسَيْنِ ، وَعَلَى عَلِيِّ بْنِ الْحُسَيْنِ وَعَلَى أَوْلادِ الْحُسَيْنِ وَعَلَى أَصْحَابِ الْحُسَيْنِ ورحمة اللَّهِ وبركاته